For Esophageal Repair

An ECM hydrogel that can halt, and possibly reverse, the progression of esophageal cancer and its precursor stages that result from gastric reflux. Esophageal cancer has a rate of growth during the past 30 years that exceeds that of any other type of cancer worldwide.

Current therapeutic options have extremely high morbidity and a mortality rate of 80% within 5 years regardless of treatment. ECM Therapeutic's product line consists of formulations that could be delivered by minimally invasive endoscopy or by oral administration.

Learn More

ECM Therapeutics, Inc. is a regenerative medicine company that develops and manufactures diagnostic and therapeutic products derived from a naturally occurring material called extracellular matrix (ECM).

About Us